To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Most Popular in Claims/Labeling
- 1Certified 'True': Food Virtues in Beauty, Part I
- 2Back to Basics, Part II: Ensuring Product Safety
- 3FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 4Cosmeservice Speeds Cleanser-to-Hand Sanitizer Registration in the EU
- 5Industry Insight: Sunscreen Myths, Claims and Consumer Confidence
- 6Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure
- 7Big Win for Cosmetics: Court Closes Prop 65 Titanium Dioxide Case
- 8The EU Fragrance Allergens
- 9Is ‘Anti-pollution’ Just a Ruse?
- 10FDA Cracks Down on Skin Lighteners
- U.S. FDA Issues 15 Warning Letters Over CBD Products
11/26/2019, Jessie Kern
- NSF International to Offer GMRA Certification and Audits
5/5/2020, Rachel Grabenhofer
- Proposed 'Natural Cosmetics Act' Gains Traction with Indies
11/6/2019, Rachel Grabenhofer
- The INCI Name Game: A Commentary
7/12/2019, Rachel Grabenhofer
- Cosmeservice Speeds Cleanser-to-Hand Sanitizer Registration in the EU
5/15/2020, Michele Behrens